[{"address1": "321 Summer Street", "address2": "Suite 400", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 330 4340", "website": "https://www.inozyme.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function. The company's lead product candidate consists of INZ-701, a soluble, recombinant, genetically engineered, and ENPP1 fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, and calciphylaxis, as well as patients with end-stage kidney disease receiving hemodialysis. It also develops Next Gen ERT for the treatment of ossification of the posterior longitudinal ligament (OPLL); and Gene therapy, a disease of the PPi-Adenosine Pathway. The company has license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Dr. Douglas A. Treco Ph.D.", "age": 66, "title": "CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 552017, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Axel  Bolte M.B.A., M.Sc.", "age": 52, "title": "Co-Founder, Senior Advisor & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 40893, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sanjay S. Subramanian M.B.A., M.S.", "age": 48, "title": "CFO, Head of Business Development, Principal Accounting Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 607383, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Winton Ph.D.", "age": 46, "title": "Senior VP & COO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 602100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Demetrios  Braddock M.D., Ph.D.", "title": "Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yves  Sabbagh Ph.D.", "title": "Senior VP, Chief Scientific Officer & Chair of the Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stefan  Riley", "title": "Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gayle  Gironda", "title": "Senior VP & Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen J. Di Palma M.B.A.", "age": 65, "title": "Consultant", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.98, "open": 3.971, "dayLow": 3.97, "dayHigh": 3.99, "regularMarketPreviousClose": 3.98, "regularMarketOpen": 3.971, "regularMarketDayLow": 3.97, "regularMarketDayHigh": 3.99, "payoutRatio": 0.0, "beta": 2.293, "forwardPE": -2.4629629, "volume": 424812, "regularMarketVolume": 424644, "averageVolume": 2075298, "averageVolume10days": 902750, "averageDailyVolume10Day": 902750, "bid": 3.98, "ask": 5.09, "bidSize": 2, "askSize": 2, "marketCap": 257601584, "fiftyTwoWeekLow": 0.721, "fiftyTwoWeekHigh": 6.24, "fiftyDayAverage": 2.23662, "twoHundredDayAverage": 2.852125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 219134064, "profitMargins": 0.0, "floatShares": 30007690, "sharesOutstanding": 64561800, "sharesShort": 3680379, "sharesShortPriorMonth": 3985553, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.056999996, "heldPercentInsiders": 0.012259999, "heldPercentInstitutions": 0.96339, "shortRatio": 0.75, "shortPercentOfFloat": 0.0616, "impliedSharesOutstanding": 64561800, "bookValue": 0.493, "priceToBook": 8.093307, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -106716000, "trailingEps": -1.68, "forwardEps": -1.62, "enterpriseToEbitda": -2.092, "52WeekChange": -0.13260871, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 3.99, "targetHighPrice": 4.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 84776000, "totalCashPerShare": 1.313, "ebitda": -104737000, "totalDebt": 46954000, "quickRatio": 1.982, "currentRatio": 2.189, "debtToEquity": 147.663, "returnOnAssets": -0.48452, "returnOnEquity": -1.4168899, "freeCashflow": -56378000, "operatingCashflow": -96523000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INZY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "postMarketChangePercent": 0.0, "postMarketPrice": 3.99, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "3.97 - 3.99", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2075298, "fiftyTwoWeekLowChange": 3.269, "fiftyTwoWeekLowChangePercent": 4.5339804, "fiftyTwoWeekRange": "0.721 - 6.24", "fiftyTwoWeekHighChange": -2.2499998, "fiftyTwoWeekHighChangePercent": -0.3605769, "fiftyTwoWeekChangePercent": -13.260871, "earningsTimestamp": 1747222200, "earningsTimestampStart": 1754310600, "earningsTimestampEnd": 1754656200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.68, "epsForward": -1.62, "epsCurrentYear": -1.24, "priceEpsCurrentYear": -3.217742, "fiftyDayAverageChange": 1.7533801, "fiftyDayAverageChangePercent": 0.78394186, "twoHundredDayAverageChange": 1.1378751, "twoHundredDayAverageChangePercent": 0.39895695, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-24", "firstTradeDateMilliseconds": 1595597400000, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": 0.251256, "regularMarketPrice": 3.99, "corporateActions": [], "postMarketTime": 1749856351, "regularMarketTime": 1749844801, "exchange": "NMS", "messageBoardId": "finmb_568596329", "market": "us_market", "hasPrePostMarketData": true, "shortName": "Inozyme Pharma, Inc.", "longName": "Inozyme Pharma, Inc.", "cryptoTradeable": false, "displayName": "Inozyme Pharma", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]